- Report
- October 2024
- 122 Pages
Global
From €4414EUR$4,650USD£3,724GBP
- Report
- October 2024
- 186 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 89 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 175 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 180 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- March 2025
- 421 Pages
Global
From €6641EUR$6,995USD£5,601GBP
- Report
- August 2024
- 180 Pages
Global
From €2278EUR$2,400USD£1,922GBP
- Report
- October 2024
- 197 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- November 2024
- 120 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- November 2024
- 338 Pages
Global
From €3323EUR$3,500USD£2,803GBP
€4747EUR$5,000USD£4,004GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- May 2024
- 185 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Drug Pipelines
- December 2024
- 80 Pages
Global
From €1899EUR$2,000USD£1,602GBP
- Report
- November 2024
- 450 Pages
Global
From €3793EUR$3,995USD£3,199GBP
- Report
- November 2024
- 250 Pages
Global
From €3793EUR$3,995USD£3,199GBP
- Report
- November 2024
- 250 Pages
Global
From €3793EUR$3,995USD£3,199GBP
- Report
- November 2024
- 500 Pages
Global
From €3793EUR$3,995USD£3,199GBP
- Report
- March 2025
- 650 Pages
Global
From €6641EUR$6,995USD£5,601GBP
- Report
- March 2025
- 402 Pages
Global
From €6641EUR$6,995USD£5,601GBP
- Report
- December 2024
- 332 Pages
Global
From €3984EUR$4,197USD£3,361GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more